Evaluating the effect of rapamycin treatment in Alzheimer’s disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol

被引：0
|
作者：
Jonas E. Svensson
Martin Bolin
Daniel Thor
Pete A. Williams
Rune Brautaset
Marcus Carlsson
Peder Sörensson
David Marlevi
Rubens Spin-Neto
Monika Probst
Göran Hagman
Anton Forsberg Morén
Miia Kivipelto
Pontus Plavén-Sigray
机构：
[1] Karolinska Institutet and Stockholm Health Care Services,Department of Clinical Neuroscience, Centre for Psychiatry Research
[2] Karolinska University Hospital,Theme Inflammation and Aging
[3] Karolinska University Hospital,Department of Medical Radiation Physics and Nuclear Medicine
[4] Karolinska Institutet,Department of Oncology
[5] St. Erik Eye Hospital,Pathology
[6] Karolinska Institutet,Department of Clinical Neuroscience, Division of Eye and Vision
[7] Karolinska Institutet,Department of Molecular Medicine and Surgery
[8] Karolinska Institutet,Department of Medicine Solna
[9] Massachusetts Institute of Technology,Institute for Medical Engineering and Science
[10] Aarhus University,Department of Dentistry and Oral Health, Section for Oral Radiology
[11] Technical University of Munich,Department of Diagnostic and Interventional Neuroradiology, Klinikum Rechts Der Isar, School of Medicine
[12] Karolinska Institutet,Department of Neurobiology, Care Sciences, and Society, Division of Clinical Geriatrics
[13] Imperial College London,Ageing Epidemiology Research Unit (AGE), School of Public Health, Faculty of Medicine
[14] University of Eastern Finland,Institute of Public Health and Clinical Nutrition
[15] Copenhagen University Hospital,Neurobiology Research Unit
来源：
BMC Neurology | / 24卷
关键词：
Rapamycin; Sirolimus; Alzheimer’s disease; Clinical trial; PET; MRI; CT; OCT; Geroprotection; Aging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The fitness for the Ageing Brain Study II (FABS II): protocol for a randomized controlled clinical trial evaluating the effect of physical activity on cognitive function in patients with Alzheimer's disease
    Elizabeth V Cyarto
    Kay L Cox
    Osvaldo P Almeida
    Leon Flicker
    David Ames
    Gerard Byrne
    Keith D Hill
    Christopher D Beer
    Dina LoGiudice
    Kana Appadurai
    Muireann Irish
    Emma Renehan
    Nicola T Lautenschlager
    [J]. Trials, 11
  • [32] The fitness for the Ageing Brain Study II (FABS II): protocol for a randomized controlled clinical trial evaluating the effect of physical activity on cognitive function in patients with Alzheimer's disease
    Cyarto, Elizabeth V.
    Cox, Kay L.
    Almeida, Osvaldo P.
    Flicker, Leon
    Ames, David
    Byrne, Gerard
    Hill, Keith D.
    Beer, Christopher D.
    LoGiudice, Dina
    Appadurai, Kana
    Irish, Muireann
    Renehan, Emma
    Lautenschlager, Nicola T.
    [J]. TRIALS, 2010, 11
  • [33] Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer's disease: An in vivo study
    Khonsari, Fatemeh
    Heydari, Mostafa
    Sharifzadeh, Mohammad
    Valizadeh, Hadi
    Dinarvand, Rassoul
    Atyabi, Fatemeh
    [J]. BIOMATERIALS ADVANCES, 2022, 137
  • [34] Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial
    Kim, Dong-Yun
    Kim, Jae Sik
    Seo, Young-Seok
    Park, Woo-Yoon
    Kim, Byoung Hyuck
    Hong, Eun-Hee
    Kim, Ji Young
    Cho, Seong-Jun
    Rhee, Hak Young
    Kim, Aryun
    Kim, Keun You
    Oh, Dae Jong
    Chung, Weon Kuu
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2023, 95 (03) : 1263 - 1272
  • [35] In vivo tau PET imaging using [11C]PBB3 in Alzheimer's disease and non-Alzheimer's disease tauopathies
    Suhara, Tetsuya
    Shimada, Hitoshi
    Shinotoh, Hitoshi
    Hirano, Shigeki
    Eguchi, Yoko
    Takahata, Keisuke
    Kimura, Yasuyuki
    Yamada, Makiko
    Ito, Hiroshi
    Higuchi, Makoto
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [36] The effect of curcumin on cognition in Alzheimer's disease and healthy aging: A systematic review of pre-clinical and clinical studies
    Voulgaropoulou, S. D.
    van Amelsvoort, T. A. M. J.
    Prickaerts, J.
    Vingerhoets, C.
    [J]. BRAIN RESEARCH, 2019, 1725
  • [37] IMAGING MICROSCOPIC NEUROPATHOLOGY OF ALZHEIMER'S DISEASE USING MRI: FROM MODEL SYSTEMS TO HUMAN IN VIVO
    Benjamini, Dan
    [J]. INNOVATION IN AGING, 2023, 7 : 386 - 386
  • [38] Evaluation of the neuroprotective effect of taurine in Alzheimer's disease using functional molecular imaging
    Oh, Se Jong
    Lee, Hae-June
    Jeong, Ye Ji
    Nam, Kyung Rok
    Kang, Kyung Jun
    Han, Sang Jin
    Lee, Kyo Chul
    Lee, Yong Jin
    Choi, Jae Yong
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] Evaluation of the neuroprotective effect of taurine in Alzheimer’s disease using functional molecular imaging
    Se Jong Oh
    Hae-June Lee
    Ye Ji Jeong
    Kyung Rok Nam
    Kyung Jun Kang
    Sang Jin Han
    Kyo Chul Lee
    Yong Jin Lee
    Jae Yong Choi
    [J]. Scientific Reports, 10
  • [40] Clinical effect and plasma concentrations of risperidone in the treatment of delirium in patients with Alzheimer's disease
    Kuniyoshi, M
    Mori, N
    Hattori, N
    Inanaga, K
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S40 - S41
12345